Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7304 p757
19 June 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacists need to manage stocks of peak flow meters as new European standard is introduced

Pharmacists need to be ready to manage the supply of peak flow meters when a new European standard for their manufacture is introduced on 1 September.

What is changing and why

Hand-held peak flow meters manufactured to a new European standard (EN 13826) are being introduced and will replace the traditional Wright scale meters currently listed in the Drug Tariff. The MHRA notes that the Wright scale is non-linear and may over-estimate peak flow in the mid-range by up to 30 per cent. “In some cases the over-reading of the Wright scale may have falsely reassured patients and their health care professionals, so that corticosteroid therapy, while appropriate, was not prescribed. This has been the main clinical driver behind the introduction of the new scales.”

The Medicines and Healthcare products Regulatory Agency has issued a notice alerting pharmacists and other health care professionals to the proposed changes (see Panel). The new peak flow meters will be CE marked and will be available on the Drug Tariff from September.

The MHRA does not make recommendations about how the change from traditional Wright meters to the new CE marked meters should be managed but states: “It is essential that the stocks of Wright and EN 13826 peak flow meters are managed correctly to ensure continuity of supply.” It points out that it can take six weeks for meters to reach pharmacies from manufacturers via wholesalers.

However, it is not clear whether Wright meters will continue to be reimbursable on NHS prescription after 1 September. The June Drug Tariff states that the CE marked meters will replace the traditional meters in the tariff from September. However, the MHRA is less clear and states: “Wright peak flow meters may still be available after [1 September], but they may not be reimbursable on NHS prescription.”

A spokesman for the Prescription Pricing Authority said he was unable to comment on the statement put out by the MHRA and that resolution of the matter was back in the hands of the Department of Health.

The MHRA points out that the results from new peak flow meters and traditional Wright meters may be different. It suggests that peak flow readings are reassessed for patients with personalised asthma action plans and that action levels are recalculated. Although meters do not need to be changed immediately, Wright meters should be replaced with the CE marked meters over the next 12 months, it says.

Back to Top


©The Pharmaceutical Journal